PhotoMedex Offers Free Seminar for Psoriasis Patients: "A Win for Your Skin in the Daily Fight Against Psoriasis"
http://www.businesswire.com/news/home/20091027006058/en
Featuring the newest XTRAC Velocity Excimer Laser therapies
MONTGOMERYVILLE, Pa.--(Business Wire)--
PhotoMedex, Inc. (Nasdaq: PHMD) a leading provider of advanced dermatology,
clinical skincare and medical laser products, is hosting a free seminar in
Indianapolis, IN on November 17, 2009. The seminar, "A Win for Your Skin in the
Daily Fight Against Psoriasis with XTRAC® Excimer Lasers," is open to the public
and will feature three prominent local physicians (from the Dermatology Group
LLC and The Dermatology Center of Indiana, LLC) explaining the New XTRAC
Velocity Laser treatments for psoriasis sufferers. The XTRAC Velocity Laser is
used in the treatment of mild, moderate, AND severe psoriasis.
Guest Speakers: Kenneth Dawes, M.D., Scott Fretzin, M.D., and Scott T. Guenther,
M.D.
Seminar overview:Numerous clinical studies have shown the dramatic difference
that "non-surgical" laser light can make in treating skin conditions such as
psoriasis. The patented XTRAC Excimer Laser from PhotoMedex targets only the
affected areas, sparing healthy surrounding skin. It is clinically proven to be
very safe, painless and highly effective.
Our guest speakers, all leading dermatologists, will explain the laser therapy
and cover the many benefits the XTRAC excimer laser treatment system offers
psoriasis sufferers, including:
* No negative systemic side effects
* No "black box" warning for cancer or serious infections
* Yes, long lasting relief, typically several months free of symptoms
* Yes, reimbursed by Medicare and most major private insurance plans
Complimentary refreshments will be provided for attendees.
Who should attend:People who suffer from mild, moderate and especially severe
psoriasis should learn how the XTRAC Velocity Excimer Laser therapy system is
the right treatment for them. We know the devastating effects psoriasis can have
on an individual`s self esteem, which is why we also encourage attendance by
family members and friends of those afflicted with psoriasis.
Date:Tuesday, November 17, 2009 from 6:30 p.m. to 7:30 p.m.
Location: Indianapolis Downtown Marriott
350 West Maryland Street
Indianapolis, IN 46225
(317) 822 - 3500
Registration:The seminar is offered free of charge by PhotoMedex and discount
coupons for parking will be provided. Attendees are invited to register by
calling the XTRAC TeleCare Center at (866) 404-3752. Space is limited, and this
seminar is expected to fill up quickly, so early registration is strongly
advised to ensure a seat.
About PhotoMedex
PhotoMedex develops proprietary excimer laser and fiber optic systems and
techniques directed toward dermatological applications, with FDA 510(k)
clearances to market the XTRAC® laser system for the treatment of psoriasis,
vitiligo, atopic dermatitis and leukoderma. The Company is a leader in the
development, manufacturing and marketing of medical laser products and services.
PhotoMedex also develops and markets products based on DNA Repair enzymes and
its patented, clinically proven Copper Peptide technology for skin health, hair
care and wound care. PhotoMedex sells directly to dermatologists, plastic and
cosmetic surgeons, and salons. ProCyte brands include Neova®, Ti-Silc®,
VitalCopper®, Simple Solutions® and AquaSanté®.
In addition, as a result of the recent merger with PhotoTherapeutics, PhotoMedex
now researches, develops and manufactures non-laser light devices for the
treatment of clinical and aesthetic dermatological conditions and adds the
Omnilux products to its portfolio. The Omnilux products incorporate a new
technology based on narrowband Light Emitting Diodes (LEDs) to treat a wide
range of dermatological conditions including acne, photodamage, and skin
rejuvenation.
This press release includes forward-looking statements within the meaning of the
"safe harbor" provisions of the Private Securities Litigation Reform Act of
1995. These statements are based on managements` current expectations and
beliefs and are subject to a number of factors and uncertainties that could
cause actual results to differ materially from those described in the
forward-looking statements.
Company Contact:
PhotoMedex, Inc.
Dennis McGrath, CEO
(215) 619-3287
info@photomedex.com
or
Investor Contacts:
Lippert/Heilshorn & Associates, Inc.
Kim Sutton Golodetz, Kgolodetz@lhai.com
(212) 838-3777
or
Bruce Voss, Bvoss@lhai.com
(310) 691-7100
Copyright Business Wire 2009
© Thomson Reuters 2009 All rights reserved



